Literature DB >> 22999166

Pursuing permanent hemodialysis vascular access in patients with a poor prognosis: juxtaposing potential benefit and harm.

Rebecca J Schmidt1, Richard S Goldman, Michael Germain.   

Abstract

For patients with end-stage renal disease requiring hemodialysis, the native arteriovenous fistula remains the gold standard of vascular access, with tunneled cuffed central venous catheters reserved for temporary use or as a last resort in patients for whom a permanent vascular access is not possible. It is expected that most patients receiving hemodialysis will be suitable for arteriovenous fistula placement, with suitable patients defined as those: (1) for whom long-term dialysis is expected to confer benefit, (2) with vascular anatomy amenable to arteriovenous fistula placement, and (3) with progressive irreversible kidney failure who are more likely to require dialysis than to die before reaching dialysis dependence. The present article reviews considerations for vascular access decision making, focusing on older patients and those with a poor prognosis, weighing the risks and benefits of arteriovenous fistulas, arteriovenous grafts, and central venous catheters and emphasizing that in the process of vascular access decision making for such patients, medical and ethical obligations to avoid central venous catheters must be balanced by the obligation to do no harm.
Copyright © 2012 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22999166     DOI: 10.1053/j.ajkd.2012.07.020

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  4 in total

1.  We Need to Train the Trainers.

Authors:  Arif Asif; Gerald A Beathard
Journal:  Clin J Am Soc Nephrol       Date:  2015-09-25       Impact factor: 8.237

Review 2.  Surgical Approach to Hemodialysis Access.

Authors:  Jarrad W Rowse; Lee Kirksey
Journal:  Semin Intervent Radiol       Date:  2016-03       Impact factor: 1.513

Review 3.  Treatment decisions for older adults with advanced chronic kidney disease.

Authors:  Steven J Rosansky; Jane Schell; Joseph Shega; Jennifer Scherer; Laurie Jacobs; Cecile Couchoud; Deidra Crews; Matthew McNabney
Journal:  BMC Nephrol       Date:  2017-06-19       Impact factor: 2.388

4.  Challenges of caring for an advanced chronic kidney disease patient with severe thrombocytopenia.

Authors:  Tetsu Akimoto; Chiharu Ito; Atsushi Kotoda; Manabu Ogura; Taro Sugase; Ryuta Sato; Eiji Kusano; Daisuke Nagata
Journal:  Clin Med Insights Case Rep       Date:  2013-11-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.